UY26387A1 - PHARMACEUTICALLY ACTIVE COMPOUNDS - Google Patents
PHARMACEUTICALLY ACTIVE COMPOUNDSInfo
- Publication number
- UY26387A1 UY26387A1 UY26387A UY26387A UY26387A1 UY 26387 A1 UY26387 A1 UY 26387A1 UY 26387 A UY26387 A UY 26387A UY 26387 A UY26387 A UY 26387A UY 26387 A1 UY26387 A1 UY 26387A1
- Authority
- UY
- Uruguay
- Prior art keywords
- active compounds
- pharmaceutically active
- pharmaceutically
- veterinarily acceptable
- compounds
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Los compuestos de fórmula (I): en la que R1, R2, R4 y R13 son como se han definido, una sal o polimorfo farmacéutica o veterinariamente aceptable de los mismos, o un solvato o profármaco farmacéutica o veterinariamente aceptable de los mismos: son inhibidores potentes y selectivos de la guanosina 3`, 5`- monofosfato cíclico fosfodiesterasa de tipo 5 (GPMc PDE5) y tienen utilidad en el tratamiento de, entre otras afecciones, la disfunción eréctil masculina (MED) y la disfunción sexual femenina (FSD).Compounds of formula (I): wherein R1, R2, R4 and R13 are as defined, a pharmaceutically or veterinarily acceptable salt or polymorph thereof, or a pharmaceutically or veterinarily acceptable solvate or prodrug thereof: are potent and selective inhibitors of guanosine 3`, 5` - cyclic monophosphate phosphodiesterase type 5 (GPMc PDE5) and have utility in the treatment of, among other conditions, male erectile dysfunction (MED) and female sexual dysfunction (FSD) .
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UY26387A UY26387A1 (en) | 2000-10-10 | 2000-10-10 | PHARMACEUTICALLY ACTIVE COMPOUNDS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UY26387A UY26387A1 (en) | 2000-10-10 | 2000-10-10 | PHARMACEUTICALLY ACTIVE COMPOUNDS |
Publications (1)
Publication Number | Publication Date |
---|---|
UY26387A1 true UY26387A1 (en) | 2001-06-29 |
Family
ID=38812252
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY26387A UY26387A1 (en) | 2000-10-10 | 2000-10-10 | PHARMACEUTICALLY ACTIVE COMPOUNDS |
Country Status (1)
Country | Link |
---|---|
UY (1) | UY26387A1 (en) |
-
2000
- 2000-10-10 UY UY26387A patent/UY26387A1/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CU23198A3 (en) | PHARMACEUTICALLY ACTIVE COMPOUNDS | |
TR200003039T2 (en) | Pirazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunctions | |
PE20040197A1 (en) | PYRAZOLOPYRIDINES SUBSTITUTED WITH CARBAMATE | |
WO2002064590A3 (en) | Carboline derivatives | |
WO2002064591A3 (en) | Carboline derivatives | |
WO2002000657A3 (en) | Condensed pyrazindione derivatives | |
NO20015275D0 (en) | Unit dosage form | |
UY28524A1 (en) | TRIAZOL DERIVATIVES REPLACED AS AN OXITOCINE ANTAGONISTS | |
DE60226970D1 (en) | PYRAZINOÄ1 ', 2': 1,6Ü-PYRIDOÄ3,4-BÜ INDOLE-1,4-DION DERIVATIVES | |
UY26387A1 (en) | PHARMACEUTICALLY ACTIVE COMPOUNDS | |
ECSP003703A (en) | PHARMACEUTICALLY ACTIVE COMPOUNDS | |
AP2002002462A0 (en) | Pharmaceutically active compounds. | |
WO2002000656A3 (en) | Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives | |
HN2000000225A (en) | PHARMACEUTICALLY ACTIVE COMPOUNDS | |
CA2451990A1 (en) | A new compound for the treatment of impotence | |
AR030681A1 (en) | PIRAZOLO COMPOUNDS [4,3-] PIRIMIDIN-7-ONAS, PHARMACEUTICAL COMPOSITION, VETERINARY FORMULATION, USE IN THE MANUFACTURE OF MEDICINAL PRODUCT, PROCEDURE FOR THE PREPARATION OF SUCH COMPOUNDS, INTERMEDIARY COMPOUNDS AND THEIR PREPARATION | |
PA8523501A1 (en) | CRYSTAL THERAPEUTIC AGENT | |
MY131573A (en) | Use of pde5 inhibitors for the treatment of premature ejaculation | |
AR028775A1 (en) | DERIVATIVES OF PYRIMIDINE AND ITS USE FOR PROFILAXIS AND THERAPY OF CEREBRAL ISCHEMIA | |
DOP2004000999A (en) | TRIAZOL DERIVATIVES REPLACED COO ANTAGONIST OF OXITOCINE | |
IL165411A0 (en) | Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterase (cGMP PDE5) for the treatment of sexual dysfunction | |
GT200400187A (en) | TRIAZOL DERIVATIVES SUBSTITUTED AS AN OXITOCINE ANTAGONISTS. | |
HN1999000041A (en) | GMPC PDE5 INHIBITING PIRAZOLIPIRIMIDINONES FOR THE TREATMENT OF SEXUAL DYSFECTION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20110715 |